Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine

Fig. 2

Analysis of the SA-IL-2 MCSCs vaccine. a Typical FCM analysis image of MCSCs anchored with SA-IL-2. b WB analysis showed that the IL-2 antibody was abundantly expressed on the vaccine. c CCK-8 assay showed that the proliferation of BMCs was stimulated by membrane bound IL-2 in a dosage dependent manner. SA-GFP was used as a control group. *P < 0.05 (vs control group) SA-IL-2 streptavidin mouse interleukin-2, MCSCs MB49 bladder cancer stem cells, WB Western blot, BMCs, bone marrow cells, GFP green fluorescent protein

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512